BUSINESS
pharmaceutical
BUSINESS
Pfizer completes Metsera acquisition in deal worth up to US$10bil
BUSINESS
UK drugmaker GSK lifts 2025 guidance despite US tariffs
BUSINESS
Trump again targets Fed’s Powell on interest rate cuts
BUSINESS
Novartis to buy US firm Avidity Biosciences for US$12bil
WORLD
India to require all drugmakers to upgrade plants following fatal cough syrup crisis
BUSINESS
Trump announces Pfizer deal he says will lower certain drug prices
BUSINESS
Expert warns ‘clear risk of recession’ if US hits Swiss pharma with 100% tariff
BUSINESS
Europe pharma group says drug tariffs would create ‘worst of all worlds’
BUSINESS
Swiss exports fall before huge US tariff
BUSINESS
Swiss economy slows after pre-tariff export rush
BUSINESS
US futures pause after steady gains on Wall Street
BUSINESS
Australia worried by Trump’s threat to raise US pharma tariffs to 250%
BUSINESS
Wall Street futures edge up amid Fed rate cut optimism, earnings in focus
BUSINESS
Pfizer’s earnings boosted by Covid-19 products, lower expenses
BUSINESS
Novo Nordisk’s shares extend losses, erasing nearly all gains since Wegovy launch
BUSINESS
Rating firms say US tariffs alone will not trigger EU sovereign downgrades
BUSINESS
AstraZeneca’s quarterly net profit jumps on record US growth
BUSINESS
European shares jump to 4-month peak on US-EU trade deal
BUSINESS
Singapore dollar faces pressure from US tariffs, policy shift
BUSINESS
Dollar drops versus euro and yen
BUSINESS
Australia ‘urgently seeking’ details on Trump drug tariff plan
BUSINESS
Asian markets mixed as Trump flags fresh tariffs, eyes on trade talks
BUSINESS